Description:
16-Dehydropregnenolone acetate is an impurity of Abiraterone, which is a CYP17A1 inhibitor and by extension androgen synthesis inhibitor. In combination with prednisone, it is indicated for the treatment of patients with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel under the trade name Zytiga.
- Molecular Weight: 356.51
- Molecular Formula: C23H32O3
Purity: > 95%
Canonical SMILES:
CC(=O)C1=CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC(=O)C)C)C
InChI:
InChI=1S/C23H32O3/c1-14(24)19-7-8-20-18-6-5-16-13-17(26-15(2)25)9-11-22(16,3)21(18)10-12-23(19,20)4/h5,7,17-18,20-21H,6,8-13H2,1-4H3/t17-,18-,20-,21-,22-,23+/m0/s1
InChIKey: MZWRIOUCMXPLKV-RFOVXIPZSA-N
- Boiling Point: 464.4±45.0 °C(Predicted)
- Melting Point: 167-170°C
- Appearance: White to Off-white Solid
- Storage: Store at 2 - 8 °C
Synonyms:
Dehydropregnenolone acetate; 16,17-Didehydropregnenolone acetate
More details are to be found on supplier website